VE822

CAS No. 1232416-25-9

VE822( VX-970 )

Catalog No. M10919 CAS No. 1232416-25-9

VE-822 is an ATR inhibitor with IC50 of 19 nM in HT29 cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 67 In Stock
5MG 65 In Stock
10MG 88 In Stock
25MG 149 In Stock
50MG 220 In Stock
100MG 352 In Stock
200MG 514 In Stock
500MG 816 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    VE822
  • Note
    Research use only, not for human use.
  • Brief Description
    VE-822 is an ATR inhibitor with IC50 of 19 nM in HT29 cells.
  • Description
    VE-822 is an ATR inhibitor with IC50 of 19 nM in HT29 cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    VX-970
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    ATM/ATR
  • Recptor
    ATM| ATR
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1232416-25-9
  • Formula Weight
    463.55
  • Molecular Formula
    C24H25N5O3S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 36 mg/mL (77.66 mM)
  • SMILES
    NC1=NC=C(C2=CC=C(S(=O)(C(C)C)=O)C=C2)N=C1C3=CC(C4=CC=C(CNC)C=C4)=NO3
  • Chemical Name
    5-(4-(isopropylsulfonyl)phenyl)-3-(3-(4-((methylamino)methyl)phenyl)isoxazol-5-yl)pyrazin-2-amine.

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1..Fokas E, et al. Cell Death Dis, 2012, 3, e44
molnova catalog
related products
  • KU 59403

    KU 59403 is a selective and potent ATM inhibitor with antitumor and anticancer activity, inhibits ATM, DNA-PK and PI3K, and is often used in combination therapy with PARP or ATR inhibitors to slow the progression of cancer.

  • GSK 635416A

    GSK 635416A is a novel ATM inhibitor with highly selective radiosensitizing activity, inhibits radiation induced phosphorylation of ATM.

  • Ro 90-7501

    Ro 90-7501 is an amyloid β42 (Aβ42) protofibrillar and TPR-dependent PP5 inhibitor, a novel radiosensitizer for cervical cancer cells, which inhibits ATM phosphorylation, promotes apoptosis, and induces cell-cycle arrest.